Switching between generic and brand-name epilepsy medication can affect seizure control. Learn the rules, what to watch for, and why logging is essential.
You collect your prescription and notice the tablets look different from last month. Same drug name, same dose, but a different colour, a different box, a different manufacturer. The pharmacist explains it's the generic version. You take it home and within two weeks, you have a breakthrough seizure after months of being seizure-free. Coincidence? Quite possibly not.
Anti-seizure medications are one of the few drug classes where switching between generic and brand-name formulations — or between different generics — can genuinely affect seizure control. This isn't a myth. It's recognised by the MHRA, NICE, and epilepsy specialists across the UK. Understanding the rules and tracking your seizures around any switch is essential.
Most generic medications are bioequivalent to their brand-name counterparts within a tight tolerance window. For most drug classes, the small variation between brands doesn't matter clinically. But anti-seizure medications have what's called a "narrow therapeutic index" — the gap between the dose that controls seizures and the dose that causes side effects (or the dose that fails to work) is small.
That means a slight variation in absorption, peak blood concentration, or release timing can be enough to push you out of the therapeutic range. Either you start having breakthrough seizures because the new formulation isn't releasing the drug quite the same way, or you start experiencing side effects because the new version peaks higher in your bloodstream.
The UK's Medicines and Healthcare products Regulatory Agency divides anti-seizure medications into three categories based on how risky switching between brands is.
Category 1 — patients should be maintained on a specific manufacturer's product. Switching is generally not recommended. Drugs in this category include phenytoin, carbamazepine, phenobarbital, and primidone.
Category 2 — the decision to switch depends on factors including seizure frequency, history, and patient anxiety. The prescriber should discuss it with the patient. This category includes valproate, lamotrigine, perampanel, topiramate, zonisamide, and several others.
Category 3 — switching is usually fine because the drugs are considered low-risk for differences. This includes levetiracetam, gabapentin, pregabalin, ethosuximide, and a few more.
If you're on a Category 1 or 2 drug, you have the right to insist on consistency. Pharmacists know this — but they don't always remember to check before dispensing. It's worth having the conversation proactively.
Sometimes a switch is unavoidable — supply shortages, manufacturer discontinuations, or pharmacy stock changes can force a change even when you'd prefer to stay on the same brand. If that happens, don't panic. The vast majority of people switch without any problems. But you should be vigilant for the first few weeks, because that's when any difference would show up.
Tip: If your medication brand changes, mark it clearly in your seizure tracker on the day you start the new version. This gives you and your neurologist a clear before-and-after picture if anything changes.
Log every seizure as you normally would, but also note:
If you experience a breakthrough seizure within four to six weeks of switching, that's a strong signal to talk to your prescriber. The same applies if side effects appear or worsen. The key word is change — anything different from your normal pattern is worth flagging.
Without consistent logging, this becomes nearly impossible to assess. You can't tell whether your seizures changed unless you have a baseline. This is one of the most concrete reasons that a reliable seizure log matters: it's the only way to detect a medication change is causing problems before it becomes serious.
You're entitled to ask your pharmacist to dispense the same brand each time. If you're on Category 1, this is standard practice. If you're on Category 2, it's a reasonable request, especially if you have a history of breakthrough seizures or if your current control is fragile. Your GP can write the prescription specifying a particular brand to make this easier.
If a switch has already happened and caused problems, your prescriber can usually arrange to switch you back. Bring your seizure log to the appointment so the conversation is grounded in evidence rather than impressions. A good seizure diary changes how these conversations go.
The UK has experienced repeated shortages of various epilepsy medications in recent years. When this happens, your pharmacy may have no choice but to substitute. The Epilepsy Society and Epilepsy Action both publish updates on current shortages and what to do if your medication is affected. Your prescriber may switch you to a different generic or even a different drug temporarily — and in either case, intensified tracking during the transition becomes essential.
The point of all this isn't to make you anxious about your medication. The vast majority of people with epilepsy take their medication every day without incident. The point is that anti-seizure drugs are unusual in how sensitive they can be to small changes, and that you have legitimate rights and reasonable strategies for protecting yourself when changes happen.
Track what you take, track when it changes, track what happens. That's the foundation of evidence-based medication management — and your seizure log is what makes it possible.
One-tap logging, automatic timestamps, PDF reports for your GP, and shared access for family and carers — all in one place.
Get Seizure Tracker →